Meeting
2022 ASCO Annual Meeting
Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.
Authors
Arya Mariam Roy
Roswell Park Cancer Institute, Buffalo, NY
Arya Mariam Roy , Changchuan Jiang , Song Yao , Stuthi Perimbeti , Shipra Gandhi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 606)
DOI
10.1200/JCO.2022.40.16_suppl.606
Abstract #
606
Poster Bd #
377
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.
First Author: Roberto Antonio Leon-Ferre
Poster
2012 ASCO Annual Meeting
Magnetic resonance imaging (MRI) evaluation of pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
First Author: Lucia Gonzalez-Cortijo
Poster
2024 ASCO Annual Meeting
Multilevel factors associated with delays to neoadjuvant chemotherapy among young adults with operable breast cancer.
First Author: Melissa Beauchemin
Poster
2023 ASCO Annual Meeting
Selective avoidance of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with HER-2 positive/triple negative breast cancer: Prospective, multi-center, single-arm study (ASLAN).
First Author: Jai Min Ryu